Pristinamycin (CAS 270076-60-3)

Pristinamycin, an antibiotic belonging to the macrolide class, displays synergistic antibacterial action. This compound inhibits bacterial growth by impeding the production of essential proteins necessary for their survival. Furthermore, Pristinamycin possesses anti-inflammatory properties, rendering it beneficial for managing certain inflammatory conditions. Extensively used in scientific research, Pristinamycin has contributed to investigations on bacterial antibiotic resistance, the development of novel antibiotics, and the exploration of existing antibiotics′ mechanisms of action. It has also facilitated studies concerning the impact of antibiotics on human cells and the formulation of new treatments for bacterial infections. Pristinamycin achieves its antibacterial effect by binding to the 50S ribosomal subunit of bacteria, hindering peptide bond formation between amino acids and thereby obstructing protein synthesis. Consequently, bacterial replication is impeded, leading to their demise.